PROCEPT BioRobotics Corp. PRCT 深 滬
已收盤 06-18 16:00:00 美东时间
21.72
+0.810
+3.87%
華盛通- 最 高21.89
- 今 開21.00
- 成交量 178.15万股
- 最 低 20.70
- 昨 收 20.91
- 總市值 12.36亿
- 52周最高 62.17
- 市盈率 靜 --
- 換手率 3.13%
- 52周最低 19.35
- 委 比 34.27%
- 總股本 5691.88万
- 歷史最高 103.8099
- 量 比 0.66
- 振 幅 5.69%
- 歷史最低 15.38
- 每 手 1
- 風險率 10.13%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Top 3 Health Care Stocks You'll Regret Missing In Q2
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give...
06-18 18:02
美股大行评级 | 甲骨文绩后分歧大！5家上调，2家下调；Navan、Hinge Health、凯西通用获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从6美元升至10美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从14美元升至14.5美元
06-12 11:32
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Rothschild & Co analyst Simon Clinch downgraded Marketaxess Holdings Inc (NASDAQ:MKTX) from Buy t...
06-11 23:42
Leerink Partners Downgrades PROCEPT BioRobotics to Market Perform, Lowers Price Target to $29
Leerink Partners analyst Mike Kratky downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Outperform to Market Perform and lowers the price target from $31 to $29.
06-11 22:33
PROCEPT BioRobotics Announces Two Milestones In Its WATER IV Prostate Cancer Clinical Program
PROCEPT BioRobotics (NASDAQ:PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: completion of enrollment in the randomized WATER IV study evaluating Aquablation® therapy versus
05-28 20:18
美股大行评级 | 潜在涨幅128.69%！Immunic获HC Wainwright & Co.升目标价至22美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immunic"买入"评级，目标价从5美元升至22美元；花旗：维持ServiceNow"买入"评级，目标价从154美元升至158美元
05-01 10:49
财报速睇 | PROCEPT BioRobotics Corp. 2026财年Q1营收0.83亿美元，同比增长20.3%；归母净利润亏损0.32亿美元，同比亏损扩大28.0%
华盛资讯5月1日讯，PROCEPT BioRobotics Corp.公布2026财年Q1业绩，公司Q1营收0.83亿美元，同比增长20.3%，归母净利润亏损0.32亿美元，同比亏损扩大28.0%。
05-01 07:32
财报速睇 | PROCEPT BioRobotics Corp. 2026财年Q1营收0.83亿美元，同比增长20.2%；归母净利润亏损0.32亿美元，同比亏损扩大27.9%
华盛资讯4月30日讯，PROCEPT BioRobotics Corp.公布2026财年Q1业绩，公司Q1营收0.83亿美元，同比增长20.2%，归母净利润亏损0.32亿美元，同比亏损扩大27.9%。
04-30 07:11
PROCEPT BioRobotics shares are trading higher after the company reported better-than-expected Q1 sales results and reaffirmed its FY2026 sales guidance.
PROCEPT BioRobotics shares are trading higher after the company reported better...
04-30 04:52
PROCEPT BioRobotics Affirms FY2026 Sales Guidance of $390.000M-$410.000M vs $396.674M Est
PROCEPT BioRobotics (NASDAQ:PRCT) affirms FY2026 sales outlook from $390.000 million-$410.000 million to $390.000 million-$410.000 million vs $396.674 million estimate.
04-30 04:21
